Spiro Rombotis

Insider Reports History

Location
Berkeley Heights, NJ
Signature
/s/ Spiro Rombotis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Spiro Rombotis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. President and CEO, Director Common Stock 68,658 $227,601 $3.32 21 Dec 2023 Direct
Cyclacel Pharmaceuticals, Inc. President and CEO, Director Stock Option (right to buy) 110,000 30 Jun 2023 Direct
Cyclacel Pharmaceuticals, Inc. President and CEO, Director Warrants (right to buy) 6,070 21 Dec 2023 Direct

Insider Reports Filed by Spiro Rombotis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CYCC Cyclacel Pharmaceuticals, Inc. 21 Dec 2023 2 +$20,122 4 President and CEO, Director 26 Dec 2023, 16:05
CYCC Cyclacel Pharmaceuticals, Inc. 30 Jun 2023 1 $0 4 President and CEO, Director 03 Jul 2023, 16:58
CYCC Cyclacel Pharmaceuticals, Inc. 31 Jan 2023 1 $0 4 President and CEO, Director 02 Feb 2023, 15:18
CYCC Cyclacel Pharmaceuticals, Inc. 13 Dec 2021 1 $0 4/A President and CEO, Director 16 Dec 2021, 15:16
CYCC Cyclacel Pharmaceuticals, Inc. 18 Nov 2021 1 +$18,000 4 President and CEO, Director 22 Nov 2021, 15:05